About pruyskart

This author has not yet filled in any details.
So far pruyskart has created 24 blog entries.

Treating abnormal breast tissue with surgery and radiotherapy reduces cancer risk but the benefits diminish with time

Latest News Treating abnormal breast tissue with surgery and radiotherapy reduces cancer risk but the benefits diminish with time A major study of women with ductal carcinoma in situ (DCIS) – a breast condition that can become invasive cancer – has shown that surgery to remove the tissue followed by radiotherapy offers better protection READ MORE

Treating abnormal breast tissue with surgery and radiotherapy reduces cancer risk but the benefits diminish with time2020-10-03T14:57:04+00:00

The mode of detection of high-risk breast cancers is linked to patient prognosis

Latest News The mode of detection of high-risk breast cancers is linked to patient prognosis Breast cancers that are detected in the interval between national screening programme mammograms have a worse prognosis than those detected at the time of a screening, even if they have the same biology, according to research presented READ MORE

The mode of detection of high-risk breast cancers is linked to patient prognosis2020-10-03T01:07:13+00:00

Researchers reveal which benign breast disease is most likely to develop into cancer

Latest News Researchers reveal which benign breast disease is most likely to develop into cancer Benign breast diseases (BBD), which are non-cancerous disorders of the breast, such as lumps, are known to increase the chances of subsequent breast cancer. Now a team of Spanish researchers have found that the way BBD is READ MORE

Researchers reveal which benign breast disease is most likely to develop into cancer2020-10-03T01:05:02+00:00

HER2+ breast cancer patients live longer if drugs given before surgery eradicate tumour

Latest News HER2+ breast cancer patients live longer if drugs given before surgery eradicate tumour Final results of nine-year survival outcomes from NeoALTTO BIG-06 trial for patients with HER2-positive breast cancer Final analysis of results from a randomised clinical trial of lapatinib and trastuzumab given before surgery in patients with early HER2-positive READ MORE

HER2+ breast cancer patients live longer if drugs given before surgery eradicate tumour2020-10-03T01:00:45+00:00

Increased risk of cardiovascular disease in women treated for breast cancer can be predicted with computer analysis of routine scans

Latest News Increased risk of cardiovascular disease in women treated for breast cancer can be predicted with computer analysis of routine scans Automated analysis of breast cancer patients’ routine scans can predict which women have a greater than one in four risk of going on to develop cardiovascular disease, according to research READ MORE

Increased risk of cardiovascular disease in women treated for breast cancer can be predicted with computer analysis of routine scans2020-10-03T00:58:06+00:00

Genetic test identifies invasive lobular carcinomas that are at high risk of recurring

Latest News Genetic test identifies invasive lobular carcinomas that are at high risk of recurring New results presented at the 12th European Breast Cancer Conference today (Friday) show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify READ MORE

Genetic test identifies invasive lobular carcinomas that are at high risk of recurring2020-10-03T00:55:13+00:00
Go to Top